Intel Corp. (INTC), Keel Infrastructure (KEEL), and Apogee Therapeutics (APGE) each reached new 52-week highs on Monday. Intel shares climbed to $141.45 driven by confidence in its chip manufacturing business and an Apple partnership announcement. Keel reached $7.37 as investors welcomed its shift from cryptocurrency mining to AI infrastructure. Apogee surged to $133 after AbbVie agreed to acquire the company in a $10.9 billion all-cash deal. The gains reflected a broader investor shift toward infrastructure, advanced computing, and healthcare sectors.
Intel Reaches $141.45 High on Manufacturing Confidence and Apple Partnership
Intel stock extended its rally, hitting a fresh all-time high of $141.45 as investors reacted positively to new partnerships and a broader rally in AI hardware stocks. The stock gained over 5% on Monday. Intel had jumped 10.6% on Thursday after President Donald Trump said Apple would use Intel's foundry services to make some of its chips, marking a major win for Intel's manufacturing business.
Intel CEO Lip-Bu Tan said he is targeting a 10-fold return for shareholders over the next five to 10 years. He highlighted Intel's work in advanced chip packaging and new technologies as key growth drivers. On Stocktwits, retail sentiment around the stock remained in 'bullish' territory.
Keel Infrastructure Hits Four-Year High Following AI Transition
Keel Infrastructure stock reached a four-year high of $7.37 on Monday, gaining over 5% as the market continued to embrace its transformation from a cryptocurrency mining business into an AI-focused infrastructure operator. The company, previously known as Bitcoin miner Bitfarms, shifted its focus to AI and high-performance computing (HPC) infrastructure in April.
Keel Infrastructure's power assets have attracted attention amid rising demand for locations capable of supporting large-scale data center projects. The company is set to join the Russell 3000 Index on June 29. Recently, it raised $458 million to support the development of its Panther Creek, Sharon, and Moses Lake data center projects as they move toward the leasing phase. Retail sentiment around the stock remained in 'bullish' territory.
Apogee Therapeutics Surges on AbbVie's $10.9 Billion Acquisition Agreement
Apogee Therapeutics stock delivered the strongest performance among the three companies, jumping 46% to a record high of $133 after AbbVie (ABBV) agreed to acquire the biotechnology company for $135.11 per share in an all-cash transaction valued at approximately $10.9 billion. The deal places a premium on Apogee's antibody-based treatment pipeline, including programs targeting inflammatory diseases.
Investors saw the acquisition as a sign that large pharmaceutical companies are looking to buy promising drug programs to support future growth and revenue. Retail sentiment around the stock remained in 'extremely bullish' territory.
So far this year, APGE stock gained 75%, while KEEL and INTC stocks surged 183% and 281%, respectively.
FAQ
What caused Intel stock to reach a 52-week high on Monday?
Intel stock hit a fresh all-time high of $141.45 on Monday, driven by growing confidence in its chip manufacturing business and positive investor reaction to President Donald Trump's announcement on Thursday that Apple would use Intel's foundry services to make some of its chips. The stock gained over 5% on Monday following a 10.6% jump on Thursday.
Why did Keel Infrastructure stock reach a four-year high?
Keel Infrastructure stock reached a four-year high of $7.37 on Monday as investors welcomed the company's transformation from cryptocurrency mining to AI-focused infrastructure. The company, previously known as Bitfarms, shifted its focus to AI and high-performance computing infrastructure in April, raised $458 million for data center projects, and is set to join the Russell 3000 Index on June 29.
How much did AbbVie agree to pay for Apogee Therapeutics?
AbbVie agreed to acquire Apogee Therapeutics for $135.11 per share in an all-cash transaction valued at approximately $10.9 billion. The deal sent Apogee stock surging 46% to a record high of $133 on Monday.
